DiaMedica Therapeutics Inc (DMAC) financials · $157.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
DiaMedica Therapeutics Inc (DMAC) $157.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$34.4M | -$26.7M |
| Net Income | -$32.8M | -$24.4M |
| EPS (Diluted) | -$0.70 | -$0.60 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $61.4M | $46.3M |
| Current Assets | $60.6M | $44.6M |
| Cash & Equivalents | $15.6M | $3.02M |
| PP&E | $145.0K | $148.0K |
| Total Liabilities | $5.26M† | $5.63M† |
| Current Liabilities | $5.13M | $5.39M |
| Shareholders' Equity | $56.1M | $40.7M |
| Retained Earnings | -$172.8M | -$140.0M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$29.1M | -$22.1M |
| CapEx | $40.0K | $25.0K |
| Investing Cash Flow | -$2.19M | $8.56M |
| Financing Cash Flow | $43.9M | $12.0M |
| Net Change in Cash | $12.6M | -$1.52M |
| Free Cash Flow | -$29.1M | -$22.1M |
FAQ
What is DMAC P/E and revenue?
DiaMedica Therapeutics Inc (DMAC) $157.4M cap.
What is DMAC revenue?
DMAC income-statement cache has no revenue figure yet.
Is DMAC profitable?
DiaMedica Therapeutics Inc last cached net income is -$32.8M (FY2025).
What are DMAC total assets?
DiaMedica Therapeutics Inc last cached total assets are $61.4M (FY2025).
What is DMAC free cash flow?
DiaMedica Therapeutics Inc last cached free cash flow is -$29.1M (FY2025).
Not investment advice. Cached statements, not a live tape.